Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 466.85M P/E - EPS this Y 70.30% Ern Qtrly Grth -
Income -37.54M Forward P/E -6.59 EPS next Y -115.80% 50D Avg Chg -10.00%
Sales - PEG -0.31 EPS past 5Y - 200D Avg Chg 4.00%
Dividend N/A Price/Book 3.41 EPS next 5Y 73.70% 52W High Chg -33.00%
Recommedations 1.40 Quick Ratio 6.42 Shares Outstanding 58.90M 52W Low Chg 61.00%
Insider Own 2.01% ROA -16.23% Shares Float 42.66M Beta 1.53
Inst Own 62.36% ROE -27.73% Shares Shorted/Prior 2.05M/1.94M Price 7.97
Gross Margin - Profit Margin - Avg. Volume 1,220,874 Target Price 9.25
Oper. Margin - Earnings Date May 2 Volume 486,154 Change -0.38%
About Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases. The company also develops ADX-629, an orally administered RASP modulator for treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa, as well as rare retinal diseases characterized by inflammation and vision loss. In addition, it develops ADX-246 in systemic immune-mediated disease; and ADX-248 in geographic atrophy. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

Aldeyra Therapeutics, Inc. News
04/06/24 Aldeyra (ALDX) Stock Rallies 43% in One Week: Here's Why
04/05/24 Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?
04/04/24 Health Care Roundup: Market Talk
04/03/24 Aldeyra's Dry Eye Disease Drug May Be on Path for FDA Approval
04/03/24 Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Is About To Turn The Corner
03/28/24 Aldeyra Therapeutics Announces Clinical Development Plan for Resubmission of New Drug Application for Reproxalap in Dry Eye Disease
03/13/24 Aldeyra Therapeutics Inc President and CEO Todd Brady Sells Company Shares
03/06/24 Here's Why You Should Invest in Aldeyra (ALDX) Stock Now
03/04/24 Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year?
03/01/24 Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics
02/29/24 5 Small Drug Stocks to Buy From a Rebounding Industry
02/22/24 Institutions own 37% of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) shares but retail investors control 37% of the company
02/06/24 Aldeyra Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
01/04/24 Aldeyra Therapeutics Provides Clinical and Regulatory Update and Announces Advancement of RASP Platform in Systemic and Retinal Inflammatory Diseases
12/19/23 Aldeyra Therapeutics Announces Statistically and Clinically Significant Improvement from Baseline in Phase 2 Clinical Trial of ADX‑629 in Patients with Atopic Dermatitis
12/18/23 Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from Phase 2 Clinical Trial of ADX-629 in Patients with Atopic Dermatitis
12/06/23 13 Hot Penny Stocks To Buy According to Hedge Funds
12/05/23 Semtech (SMTC) to Release Q3 Earnings: What's in the Cards?
12/05/23 Should You Buy Aldeyra Therapeutics (ALDX) Ahead of Earnings?
11/27/23 Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Dry Eye Disease
ALDX Chatroom

User Image smen05 Posted - 6 hours ago

$ALDX and down it comes 😂

User Image johnnygogogo Posted - 8 hours ago

$ALDX the idea of selling this for a profit right now is both foreign and hilarious.

User Image BeefStewart Posted - 8 hours ago

$ALDX Anyone making money today (including - perhaps especially - those taking profits) should be very grateful, given the utterly chaotic state of the markets, in my opinion. Congratulations to those who sold for a profit, and best of luck to those who are holding out for hopefully brighter days ahead.

User Image Kingjake26 Posted - 9 hours ago

$ALDX Nice. :)).

User Image nycpupster Posted - 9 hours ago

$ALDX some fud in this stock, but one of the few positive stocks out there from a fundamentals and momentum perspective. FUD might be real, that is the risk. If there are no real regulatory issues, this stock is worth $100s, I bought in the 55s, waiting for it to cool down to $59s to accumulate more if I can get it. Prob an easy bounce to low 70s.

User Image TagyouRit Posted - 10 hours ago

$ALDX nibbled a few in the threes

User Image GoldmanSlaps Posted - 10 hours ago

$ALDX order flow looks really nice today going other way of most smalls

User Image GoldmanSlaps Posted - 10 hours ago

$ALDX smells like news is coming 🤷🏼‍♂️

User Image NatalieBarkerx Posted - 11 hours ago

$MULN $AMC $ALDX Leading analysts' thoughts,,.👇

User Image johnnygogogo Posted - 22 hours ago

$ALDX for all you gap close chart jockeys, consider that Perceptive’s only real exit is an outright sale (or a major indexation event). Also consider the valuation if that ever occurs to you. ABBV is driving discussions with FDA imo, but to any of you who think they are just buying to shelve, there are protections in the agreement that would revert the Reprox rights to ALDX if ABBV doesn’t exercise the option within a certain period of time at key benchmarks.

User Image RigidFlexibility Posted - 1 day ago

$ALDX C’mon head shed, throw us a news bone to help this sh price. Down 39 percent myself but sticking with it till BO or thru approvals and revenue explosions. Yeah, I know, Feds, BRICS, and other World chaos don’t help the market. GLTA

User Image nycpupster Posted - 1 day ago

$ALDX sadly, this is the kind of market where wall street tells you to buy and hold, meanwhile as the price action here tells you, they are gap filling, liquidity mining and all kinds of nonsense. As I mentioned before there's a gap at around $3.60-$3.80. If support doesn't hold here, we prob gap down to $3.60

User Image C0nny1 Posted - 1 day ago

$ALDX looks like if perceptive doesn't buy, no one does😂

User Image MontanaT Posted - 1 day ago

$ALDX only bad if you can’t buy dip🤷🏻‍♂️

User Image Rounderssss4 Posted - 1 day ago

$AUPH when this was 8 I gave @TheGunnerAB $AVDL @ 9.00 , he said don't trust this guy, because of $ALDX drop , Well ALDX came back, and AVDL has doubled meanwhile he went balls deep in $PDSB which has been an absolute disaster just like auph🤗, he missed out on 100% rally on avdl suck on that, what a loser @TheGunnerAB

User Image StockednLoaded Posted - 1 day ago

$ALDX - Have there been any studies comparing Reproxalap to Pataday or Lastacaft? Is there unmet need here or just an attempt at improving dry eye and conjunctivitis?

User Image smen05 Posted - 1 day ago

$ALDX sold my position .. I think the markets going to tank in general .. Israel will attack in the coming days .. I will get in at lower price ..later ..

User Image MontanaT Posted - 1 day ago

$ALDX sneak peek at 5.25 this is a no brainer

User Image MewKitty Posted - 1 day ago

$ALDX Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024 This ad posted by Palatin on IBRX message board. Anyone have info on it? Go to company website....

User Image footlsfoot Posted - 2 days ago

$ALDX worst investment I’ve every made

User Image MontanaT Posted - 2 days ago

$ALDX literally a dip to buy

User Image MontanaT Posted - 5 days ago

$ALDX ignore all this daily focus on main goal , almost there ;)

User Image C0nny1 Posted - 5 days ago

$ALDX at least we got enough cash and low debt. XBI and small caps getting crushed. Market situation bothers me tbh...

User Image GoldmanSlaps Posted - 5 days ago

$ALDX holding up incredibly well nasty out there

User Image Finnisher2M Posted - 5 days ago


User Image johnnygogogo Posted - 6 days ago

$ALDX if Perceptive bought this up to $4.75 just a few days ago, what’s stopping you from adding?

User Image ClaimsMonitoring Posted - 6 days ago

$ALDX ATTENTION LONG-TERM ALDEYRA THERAPEUTICS, INC. (NASDAQ: ALDX) INVESTORS Grabar Law Office is investigating claims on behalf of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shareholders. The investigation concerns whether certain officers of Aldeyra have breached their fiduciary duties owed to the company. Current Aldeyra shareholders who have continuously held Aldeyra shares since prior to January 7, 2021 should click here: https://grabarlaw.com/the-latest/aldeyra-sahreholder-investigation/. You can seek corporate reforms, the return of funds back to company coffers, and a court approved incentive award at no cost to you whatsoever. Contact Joshua H. Grabar at [email protected] or Mia R. Heller at [email protected], or call 267-507-6085. $ALDX #Aldeyra

User Image nycpupster Posted - 6 days ago

$ALDX I kind of just want to rip off the band aid and have it test the gap at $4 and be done with this daily nonsense

User Image VIPTrades009 Posted - 1 week ago

$ALDX again on high watch tomorrow and friday….

User Image GoldmanSlaps Posted - 1 week ago

$ALDX brutal day out there guys stay safe

Analyst Ratings
Oppenheimer Outperform Apr 3, 24
Citigroup Buy Oct 17, 23
Oppenheimer Perform Oct 17, 23
Oppenheimer Outperform Aug 9, 23
HC Wainwright & Co. Buy Jun 30, 23
HC Wainwright & Co. Buy Jun 22, 23
HC Wainwright & Co. Buy Jun 16, 23
Citigroup Buy Jun 1, 23
HC Wainwright & Co. Buy May 5, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
PERCEPTIVE ADVISORS LLC 10% Owner 10% Owner Oct 16 Sell 1.67 2,756,499 4,603,353 8,593,586 10/18/23
Brady Todd C President and CEO President and CEO Sep 07 Option 0.55 273,058 150,182 1,728,343 09/11/23
PERCEPTIVE ADVISORS LLC 10% Owner 10% Owner Aug 08 Buy 7.24 97,000 702,280 11,235,085 08/10/22
PERCEPTIVE ADVISORS LLC 10% Owner 10% Owner Aug 04 Buy 6.17 95,100 586,767 10,997,085 08/08/22
PERCEPTIVE ADVISORS LLC 10% Owner 10% Owner Aug 01 Buy 5.05 144,185 728,134 10,389,579 08/03/22
PERCEPTIVE ADVISORS LLC 10% Owner 10% Owner Jul 28 Buy 5.00 119,392 596,960 10,023,271 08/01/22
JOYCE MARTIN JOSEPH Director Director Jun 23 Buy 3.4755 4,323 15,025 23,967 06/27/22
Brady Todd C President and CEO President and CEO Jun 23 Buy 3.3642 17,700 59,546 1,216,535 06/27/22
- - - Jan 11 Buy 8.79 1,050,000 9,229,500 7,335,458 01/11/21